Michael Egholm - Fluidigm CEO Pres
| FLB Stock | EUR 1.82 0.10 5.81% |
Insider
Michael Egholm is CEO Pres of Fluidigm
| Age | 60 |
| Phone | 650 266 6000 |
| Web | https://www.fluidigm.com |
Michael Egholm Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Egholm against Fluidigm stock is an integral part of due diligence when investing in Fluidigm. Michael Egholm insider activity provides valuable insight into whether Fluidigm is net buyers or sellers over its current business cycle. Note, Fluidigm insiders must abide by specific rules, including filing SEC forms every time they buy or sell Fluidigm'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Egholm over a week ago Disposition of 28795 shares by Michael Egholm of Standard Biotools at 1.51 subject to Rule 16b-3 | ||
Michael Egholm over six months ago Disposition of 196512 shares by Michael Egholm of Standard Biotools subject to Rule 16b-3 |
Fluidigm Management Efficiency
The company has return on total asset (ROA) of (0.2183) % which means that it has lost $0.2183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.1721) %, meaning that it generated substantial loss on money invested by shareholders. Fluidigm's management efficiency ratios could be used to measure how well Fluidigm manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Sandy Pound | Thermo Fisher Scientific | N/A | |
| Andrew Markwick | IQVIA Holdings | N/A | |
| Stephen Williamson | Thermo Fisher Scientific | 56 | |
| Christopher Bouda | Danaher | N/A | |
| John Bedford | Danaher | N/A | |
| Angela Lalor | Danaher | 58 | |
| Joakim Weidemanis | Danaher | 54 | |
| Rainer Blair | Danaher | 59 | |
| Karl Guenault | IQVIA Holdings | N/A | |
| Marc Casper | Thermo Fisher Scientific | 55 | |
| Ronald Bruehlman | IQVIA Holdings | 62 | |
| Michael Esq | Thermo Fisher Scientific | 61 | |
| Ryan Snyder | Thermo Fisher Scientific | N/A | |
| Jeffrey Spaeder | IQVIA Holdings | N/A | |
| Matthew McGrew | Danaher | 51 | |
| Mitchell Rales | Danaher | 66 | |
| Michel Lagarde | Thermo Fisher Scientific | 48 | |
| Gianluca Pettiti | Thermo Fisher Scientific | 44 | |
| Rafael Tejada | Thermo Fisher Scientific | N/A | |
| Karen Nelson | Thermo Fisher Scientific | N/A | |
| Steven Rales | Danaher | 72 | |
Management Performance
| Return On Equity | -1.17 | |||
| Return On Asset | -0.22 |
Fluidigm Leadership Team
Elected by the shareholders, the Fluidigm's board of directors comprises two types of representatives: Fluidigm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fluidigm. The board's role is to monitor Fluidigm's management team and ensure that shareholders' interests are well served. Fluidigm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fluidigm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Egholm, CEO Pres | ||
| Mark Spearman, Sr Communications | ||
| David King, VP RD | ||
| Dr Dphil, CoFounder Board | ||
| Peter DeNardo, Investor Relations | ||
| Stephen Linthwaite, President CEO, COO, Director | ||
| Andrew Quong, Chief Officer | ||
| Hanjoon Kim, Chief Officer | ||
| Vikram Jog, Chief Officer | ||
| Angela Peters, Chief Officer | ||
| Rafael AguirreSacasa, Acting Counsel |
Fluidigm Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fluidigm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.17 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (1.94) % | |||
| Operating Margin | (1.19) % | |||
| Current Valuation | 23.67 M | |||
| Shares Outstanding | 79.3 M | |||
| Shares Owned By Institutions | 64.53 % | |||
| Price To Book | 7.07 X | |||
| Price To Sales | 1.04 X | |||
| Revenue | 97.95 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Fluidigm Stock
Fluidigm financial ratios help investors to determine whether Fluidigm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluidigm with respect to the benefits of owning Fluidigm security.